ICU Medical [ICUI] Stock Gets Reiterated At KeyBanc. It’s Still Overweight
KeyBanc maintained its ICU Medical [ICUI] rating to the equivalent of Overweight but changed the price target to $236 from $222, in a research note dated 2021-01-08. That figure represents around a 7.28% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with KeyBanc Capital Markets’s analysts upgrading the […]